Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
In Q3 2021, Chinese residents’ expenditures on medicine and medical services continued to increase. Per capita spending of urban residents reached RMB 635, up by 10.8% y/y, and that of rural residents recorded a growth of 9 ...
View more details
As the global epidemic is being contained and China’s economic growth has returned to normal, the growth of the country's healthcare sector is likely to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the ...
View more details
China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered in public hospitals and basic medical institutions. However, due to the growing demand ...
View more details
Since China initiated 5G technology R&D and standard formulation in 2013, the landmark national-level policy has been Made in China 2025 issued by the State Council in 2015. 5G technology, along with integrated circuits ...
View more details
The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth relative to the rest of the world has contributed to ...
View more details
In Q3 2020, manufacturing operations in China were completely resumed, and most of the pharmaceutical companies increased their production to meet the growing demand. The demand for COVID-19 related drugs, protective ...
View more details